These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 6148252

  • 21. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S, Cabib S.
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [Abstract] [Full Text] [Related]

  • 22. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR, Mueller RA.
    Eur J Pharmacol; 1985 Jul 11; 113(1):109-14. PubMed ID: 2864260
    [Abstract] [Full Text] [Related]

  • 23. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 11; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 24. Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats.
    Fenton HM, Leszczak E, Gerhardt S, Liebman JM.
    Eur J Pharmacol; 1984 Nov 13; 106(2):363-72. PubMed ID: 6442233
    [Abstract] [Full Text] [Related]

  • 25. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA.
    J Pharmacol Exp Ther; 1985 Nov 13; 235(2):287-95. PubMed ID: 3932640
    [Abstract] [Full Text] [Related]

  • 26. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 13; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 27. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 13; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 28. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Feb 13; 20(2):589-97. PubMed ID: 2953990
    [Abstract] [Full Text] [Related]

  • 29. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
    Andersen PH, Nielsen EB, Scheel-Krüger J, Jansen JA, Hohlweg R.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):291-2. PubMed ID: 2956116
    [No Abstract] [Full Text] [Related]

  • 30. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
    Barone P, Davis TA, Braun AR, Chase TN.
    Eur J Pharmacol; 1986 Apr 09; 123(1):109-14. PubMed ID: 2872071
    [Abstract] [Full Text] [Related]

  • 31. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 32. Unilateral injections of a D2 but not D1 agonist into the frontal cortex of rats produce a contralateral directional bias.
    Beninger RJ, Musgrave MA, Dickson PR.
    Pharmacol Biochem Behav; 1990 Nov 07; 37(3):387-92. PubMed ID: 1982354
    [Abstract] [Full Text] [Related]

  • 33. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G, Jaton AL, Vigouret JM.
    Neurosci Lett; 1988 May 16; 88(1):69-74. PubMed ID: 2969468
    [Abstract] [Full Text] [Related]

  • 34. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.
    Asin KE, Montana WE.
    Pharmacol Biochem Behav; 1988 Jan 16; 29(1):89-92. PubMed ID: 3258427
    [Abstract] [Full Text] [Related]

  • 35. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR, Chase TN.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):301-6. PubMed ID: 3493161
    [Abstract] [Full Text] [Related]

  • 36. Production of climbing behaviour in mice requires both D1 and D2 receptor activation.
    Moore NA, Axton MS.
    Psychopharmacology (Berl); 1988 Nov 19; 94(2):263-6. PubMed ID: 2895485
    [Abstract] [Full Text] [Related]

  • 37. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R, Gandolfi O, Vaccheri A, Roncada P, Montanaro N.
    Psychopharmacology (Berl); 1988 Nov 19; 95(3):381-5. PubMed ID: 2901128
    [Abstract] [Full Text] [Related]

  • 38. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE, Mueller RA, Breese GA.
    Eur J Pharmacol; 1989 Jan 10; 159(2):141-7. PubMed ID: 2495973
    [Abstract] [Full Text] [Related]

  • 39. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats.
    Gilbert DB, Cooper SJ.
    Brain Res Bull; 1985 Oct 10; 15(4):385-9. PubMed ID: 2933127
    [Abstract] [Full Text] [Related]

  • 40. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 10; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.